I feel compelled to rebut several misrepresentations made by Mark Case, BGE’s vice president of regulatory policy, in a recent article, “Electrification will strain Maryland’s grid. The question is by ...
Primary Sclerosing Cholangitis (PSC) is a debilitating rare disease of the liver with no effective treatment. Reported in Nature Genetics researchers from the Wellcome Trust Sanger Institute, Mayo ...
The last time I spoke about Mirum Pharmaceuticals, Inc. (MIRM) it was in a Seeking Alpha article entitled "Mirum Pharmaceuticals: After Phase 2 Miss, An iBAT Inhibitor On Deck To Drive Value." With ...
SAN FRANCISCO--(BUSINESS WIRE)--Perspectum announced recruitment of the first patient in a multi-center collaborative study to characterize Primary Sclerosing Cholangitis in children, “Prospective ...
Table 1 Association summary statistics across four newly associated PSC risk loci In summary, we performed the largest genome-wide association study of PSC to date and identified four new PSC risk ...
Phase I study of weekly outpatient paclitaxel and concurrent cranial irradiation in adults with astrocytomas. Thirty-four patients were treated with 53 cycles of PSC 833 and etoposide. Steady-state ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results